Compare RCEL & SPXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCEL | SPXX |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 226 | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.0M | 314.9M |
| IPO Year | N/A | 2005 |
| Metric | RCEL | SPXX |
|---|---|---|
| Price | $4.40 | $16.74 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.88 | N/A |
| AVG Volume (30 Days) | ★ 216.1K | 49.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $21.69 | N/A |
| Revenue Next Year | $49.58 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.22 | $14.33 |
| 52 Week High | $10.28 | $18.35 |
| Indicator | RCEL | SPXX |
|---|---|---|
| Relative Strength Index (RSI) | 45.04 | 27.59 |
| Support Level | $4.11 | N/A |
| Resistance Level | $4.57 | $18.18 |
| Average True Range (ATR) | 0.37 | 0.22 |
| MACD | -0.08 | -0.09 |
| Stochastic Oscillator | 5.52 | 1.43 |
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on approximately 35%-75% of the notional value of the Fund's equity portfolio in an effort to enhance the Fund's risk-adjusted returns.